Comparison Results
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh
―
R$120.19B
8,811.26
-62.49%
―
BeiGene Ltd ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR
―
R$225.15B
―
11.71%
―
Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs
―
R$203.90B
95,973.85
45.73%
―
Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
―
R$193.81B
41,886.23
137.35%
―
IQVIA Holdings Inc Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
―
R$239.61B
34,670.63
25.84%
―
Teva Pharmaceutical Industries Ltd Unsponsored Brazilian Depositary Receipt Repr 0.5 ADR
―
R$257.98B
―
106.98%
―
Performance Comparison
BR:A1LN34
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh
45.00
-71.28
-61.30%
BR:B1ME34
BeiGene Ltd ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR
80.32
8.42
11.71%
BR:BIIB34
Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs
193.80
59.40
44.20%
BR:I1LM34
Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
255.15
126.70
98.64%
BR:I1QV34
IQVIA Holdings Inc Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
93.42
19.18
25.84%
BR:T1EV34
Teva Pharmaceutical Industries Ltd Unsponsored Brazilian Depositary Receipt Repr 0.5 ADR
106.80
51.81
94.22%